Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Clinical Outcome
21 results:

  • 1. DNA Methylation Analysis to predict Regression of high-grade anal Intraepithelial Neoplasia in HIV+ men (MARINE): a cohort study protocol.
    Dias Gonçalves Lima F; van der Zee RP; Dick S; van Noesel CJM; Berkhof J; Schim van der Loeff MF; Prins JM; Steenbergen RDM; de Vries HJC
    BMJ Open; 2022 Aug; 12(8):e060301. PubMed ID: 35922105
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Biomarker p16 predicts progression risk of anal low-grade squamous intraepithelial lesions.
    Liu Y; Blakely M; Sigel K; Thin TH; Hui P; Donovan M; Gaisa MM
    AIDS; 2018 Oct; 32(16):2309-2316. PubMed ID: 30005024
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy.
    Foster CC; Lee AY; Furtado LV; Hart J; Alpert L; Xiao SY; Hyman NH; Sharma MR; Liauw SL
    PLoS One; 2018; 13(3):e0194234. PubMed ID: 29522569
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy.
    Rödel F; Martin D; Helmke C; Balermpas P; Fokas E; Wieland U; Rave-Fränk M; Kitz J; Matthess Y; Raab M; Strebhardt K; Rödel C
    Oncotarget; 2016 Aug; 7(33):53339-53349. PubMed ID: 27462786
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic colorectal cancer.
    Kim SH; Park KH; Shin SJ; Lee KY; Kim TI; Kim NK; Rha SY; Roh JK; Ahn JB
    Cancer Res Treat; 2016 Jan; 48(1):208-15. PubMed ID: 25943321
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The prognostic value of HPV status and p16 expression in patients with carcinoma of the anal canal.
    Roldán Urgoiti GB; Gustafson K; Klimowicz AC; Petrillo SK; Magliocco AM; Doll CM
    PLoS One; 2014; 9(10):e108790. PubMed ID: 25271758
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer.
    Meyer JE; Panico VJ; Marconato HM; Sherr DL; Christos P; Pirog EC
    J Gastrointest Cancer; 2013 Dec; 44(4):450-5. PubMed ID: 24014082
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Signature patterns of human papillomavirus type 16 in invasive anal carcinoma.
    Valmary-Degano S; Jacquin E; Prétet JL; Monnien F; Girardo B; Arbez-Gindre F; Joly M; Bosset JF; Kantelip B; Mougin C
    Hum Pathol; 2013 Jun; 44(6):992-1002. PubMed ID: 23266444
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Methylation of the polycomb group target genes is a possible biomarker for favorable prognosis in colorectal cancer.
    Dallol A; Al-Maghrabi J; Buhmeida A; Gari MA; Chaudhary AG; Schulten HJ; Abuzenadah AM; Al-Ahwal MS; Sibiany A; Al-Qahtani MH
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2069-75. PubMed ID: 23010642
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Characterization of cdkn2a(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing.
    Bihl MP; Foerster A; Lugli A; Zlobec I
    J Transl Med; 2012 Aug; 10():173. PubMed ID: 22925370
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Interrater agreement of anal cytology.
    Darragh TM; Tokugawa D; Castle PE; Follansbee S; Borgonovo S; LaMere BJ; Schwartz L; Gage JC; Fetterman B; Lorey T; Wentzensen N
    Cancer Cytopathol; 2013 Feb; 121(2):72-8. PubMed ID: 22811048
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MTHFR, MTR, and MTRR polymorphisms in relation to p16ink4a hypermethylation in mucosa of patients with colorectal cancer.
    Wettergren Y; Odin E; Carlsson G; Gustavsson B
    Mol Med; 2010; 16(9-10):425-32. PubMed ID: 20549016
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Baba Y; Nosho K; Shima K; Goessling W; Chan AT; Ng K; Chan JA; Giovannucci EL; Fuchs CS; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):822-31. PubMed ID: 20200425
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype.
    Ogino S; Nosho K; Irahara N; Meyerhardt JA; Baba Y; Shima K; Glickman JN; Ferrone CR; Mino-Kenudson M; Tanaka N; Dranoff G; Giovannucci EL; Fuchs CS
    Clin Cancer Res; 2009 Oct; 15(20):6412-20. PubMed ID: 19825961
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer.
    Kure S; Nosho K; Baba Y; Irahara N; Shima K; Ng K; Meyerhardt JA; Giovannucci EL; Fuchs CS; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2765-72. PubMed ID: 19789368
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
    Nosho K; Shima K; Irahara N; Kure S; Firestein R; Baba Y; Toyoda S; Chen L; Hazra A; Giovannucci EL; Fuchs CS; Ogino S
    Mod Pathol; 2009 Jul; 22(7):922-32. PubMed ID: 19430421
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype.
    Nosho K; Shima K; Kure S; Irahara N; Baba Y; Chen L; Kirkner GJ; Fuchs CS; Ogino S
    Neoplasia; 2009 Jan; 11(1):87-95. PubMed ID: 19107235
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
    Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH
    Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.
    Ogino S; Nosho K; Kirkner GJ; Kawasaki T; Meyerhardt JA; Loda M; Giovannucci EL; Fuchs CS
    Gut; 2009 Jan; 58(1):90-6. PubMed ID: 18832519
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. p16ink4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer.
    Wettergren Y; Odin E; Nilsson S; Carlsson G; Gustavsson B
    Mol Med; 2008; 14(7-8):412-21. PubMed ID: 18418463
    [TBL] [Abstract] [Full Text] [Related]  


    of 2.